These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26625702)

  • 21. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.
    Cabilly Y; Barbi M; Geva M; Marom L; Chetrit D; Ehrlich M; Elroy-Stein O
    PLoS One; 2012; 7(10):e46715. PubMed ID: 23056417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
    Wortham NC; Proud CG
    BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eIF2B: recent structural and functional insights into a key regulator of translation.
    Wortham NC; Proud CG
    Biochem Soc Trans; 2015 Dec; 43(6):1234-40. PubMed ID: 26614666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of endoplasmic reticulum stress and autophagy on H2O2‑induced oxidative stress injury in HepG2 cells.
    Wu Z; Wang H; Fang S; Xu C
    Mol Med Rep; 2018 Nov; 18(5):4163-4174. PubMed ID: 30221706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.
    Kantor L; Harding HP; Ron D; Schiffmann R; Kaneski CR; Kimball SR; Elroy-Stein O
    Hum Genet; 2005 Oct; 118(1):99-106. PubMed ID: 16041584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.
    Herrero M; Mandelboum S; Elroy-Stein O
    Neuromolecular Med; 2019 Sep; 21(3):303-313. PubMed ID: 31134486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis.
    Xu L; Zhong M; Yang Y; Wang M; An N; Xu X; Zhu Y; Li Z; Chen H; Zhao R; Zheng X
    Neurol Sci; 2022 Apr; 43(4):2659-2667. PubMed ID: 34755279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
    La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
    Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.
    Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C
    Elife; 2018 Feb; 7():. PubMed ID: 29489452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome.
    Ferreira MC; Dorboz I; Boespflug-Tanguy O
    Clin Biochem; 2015 Dec; 48(18):1317-23. PubMed ID: 26162493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.
    van Kollenburg B; van Dijk J; Garbern J; Thomas AA; Scheper GC; Powers JM; van der Knaap MS
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):707-15. PubMed ID: 16825957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?
    Carter CJ
    Schizophr Bull; 2007 Nov; 33(6):1343-53. PubMed ID: 17329232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The life and death of oligodendrocytes in vanishing white matter disease.
    Van Haren K; van der Voorn JP; Peterson DR; van der Knaap MS; Powers JM
    J Neuropathol Exp Neurol; 2004 Jun; 63(6):618-30. PubMed ID: 15217090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vanishing white matter.
    van der Knaap MS; Bugiani M; Abbink TEM
    Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter].
    Leng XR; Wu Y; Jiang YW
    Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999
    [No Abstract]   [Full Text] [Related]  

  • 39. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
    Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
    Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Standing Psychiatric Features as the Only Clinical Presentation of Vanishing White Matter Disease.
    Accogli A; Brais B; Tampieri D; La Piana R
    J Neuropsychiatry Clin Neurosci; 2019; 31(3):276-279. PubMed ID: 31046592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.